Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDT NASDAQ:GH NYSE:HIMS NASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$12.78+0.9%$12.36$10.10▼$20.72$1.82B0.3369,650 shs253,463 shsGHGuardant Health$65.06-2.2%$52.71$20.14▼$68.00$8.29B1.462.66 million shs1.91 million shsHIMSHims & Hers Health$44.50+7.2%$50.02$13.47▼$72.98$9.57B2.1427.55 million shs30.42 million shsOPCHOption Care Health$28.93+1.7%$29.42$21.39▼$35.53$4.62B0.821.72 million shs1.90 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health+0.38%+0.81%+23.83%-13.13%-33.79%GHGuardant Health-2.18%+2.46%+47.23%+34.39%+164.79%HIMSHims & Hers Health+6.91%+0.98%-29.79%-15.75%+207.23%OPCHOption Care Health+1.72%+1.19%+2.37%-10.07%-10.63%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARDTArdent Health3.5743 of 5 stars3.40.00.00.03.60.03.1GHGuardant Health3.7246 of 5 stars1.54.00.04.43.52.50.6HIMSHims & Hers Health3.3052 of 5 stars2.02.00.00.03.43.33.1OPCHOption Care Health4.7719 of 5 stars2.45.00.04.34.43.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health 2.70Moderate Buy$19.5653.08% UpsideGHGuardant Health 3.06Buy$57.50-11.62% DownsideHIMSHims & Hers Health 1.92Reduce$38.92-12.55% DownsideOPCHOption Care Health 2.89Moderate Buy$35.7523.57% UpsideCurrent Analyst Ratings BreakdownLatest ARDT, HIMS, OPCH, and GH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/19/2025HIMSHims & Hers HealthZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/18/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$48.00 ➝ $37.008/11/2025ARDTArdent HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$18.00 ➝ $15.008/7/2025ARDTArdent HealthKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$24.00 ➝ $20.008/5/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold7/31/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Outperform ➝ Market Outperform$36.00 ➝ $38.007/31/2025OPCHOption Care HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform7/31/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$57.00 ➝ $60.007/31/2025GHGuardant HealthRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$59.00 ➝ $61.007/17/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$45.00 ➝ $48.007/16/2025ARDTArdent HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeNeutral ➝ Underperform$15.50 ➝ $14.60(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health$5.97B0.31$2.56 per share5.00$11.52 per share1.11GHGuardant Health$739.02M10.98N/AN/A($2.45) per share-26.56HIMSHims & Hers Health$1.48B6.81$0.37 per share120.26$2.49 per share17.87OPCHOption Care Health$5.00B0.94$1.66 per share17.43$8.38 per share3.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health$210.34M$1.817.066.525.614.11%16.66%5.18%11/5/2025 (Estimated)GHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%11/5/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.8055.6385.582.869.63%26.26%13.06%11/3/2025 (Estimated)OPCHOption Care Health$211.82M$1.2523.1422.961.753.93%17.53%7.17%10/29/2025 (Estimated)Latest ARDT, HIMS, OPCH, and GH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025ARDTArdent Health$0.30$0.52+$0.22$0.52$1.54 billion$1.65 billion8/4/2025Q2 2025HIMSHims & Hers Health$0.18$0.17-$0.01$0.17$550.06 million$544.83 million7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 million7/30/2025Q2 2025OPCHOption Care Health$0.40$0.41+$0.01$0.31$1.35 billion$1.42 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent HealthN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health0.662.132.00GHGuardant HealthN/A3.713.35HIMSHims & Hers Health1.724.984.46OPCHOption Care Health0.811.521.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent HealthN/AGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipARDTArdent Health1.70%GHGuardant Health6.10%HIMSHims & Hers Health17.71%OPCHOption Care Health0.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health24,900143.11 million140.67 millionOptionableGHGuardant Health2,021124.71 million117.10 millionNot OptionableHIMSHims & Hers Health1,637226.02 million185.99 millionOptionableOPCHOption Care Health8,088162.29 million161.26 millionOptionableARDT, HIMS, OPCH, and GH HeadlinesRecent News About These CompaniesDurable Capital Partners LP Invests $122.91 Million in Option Care Health, Inc. $OPCHSeptember 3 at 7:50 AM | marketbeat.comCubist Systematic Strategies LLC Takes $12.38 Million Position in Option Care Health, Inc. $OPCHSeptember 3 at 6:57 AM | marketbeat.comAmerican Century Companies Inc. Sells 1,223,779 Shares of Option Care Health, Inc. $OPCHSeptember 3 at 3:47 AM | marketbeat.comAnalysts Set Option Care Health, Inc. (NASDAQ:OPCH) Price Target at $35.75September 3 at 2:25 AM | americanbankingnews.comThe Manufacturers Life Insurance Company Increases Stock Holdings in Option Care Health, Inc. $OPCHSeptember 2 at 6:05 AM | marketbeat.comOption Care Health, Inc. $OPCH Shares Sold by Trexquant Investment LPSeptember 2 at 5:43 AM | marketbeat.comLandscape Capital Management L.L.C. Sells 9,735 Shares of Option Care Health, Inc. $OPCHSeptember 2 at 5:26 AM | marketbeat.comAlphaQuest LLC Lowers Position in Option Care Health, Inc. $OPCHSeptember 2 at 4:21 AM | marketbeat.comCreativeOne Wealth LLC Increases Position in Option Care Health, Inc. $OPCHSeptember 1 at 4:54 AM | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSeptember 1 at 2:09 AM | marketbeat.comOption Care Health, Inc. $OPCH Position Trimmed by Expect Equity LLCAugust 31, 2025 | marketbeat.comGamco Investors INC. ET AL Sells 17,302 Shares of Option Care Health, Inc. $OPCHAugust 31, 2025 | marketbeat.comOption Care Health, Inc. $OPCH Shares Sold by Gabelli Funds LLCAugust 29, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 10,080 Shares of Option Care Health, Inc. $OPCHAugust 29, 2025 | marketbeat.comTeca Partners LP Makes New $13.46 Million Investment in Option Care Health, Inc. $OPCHAugust 28, 2025 | marketbeat.com179,219 Shares in Option Care Health, Inc. $OPCH Purchased by Walleye Capital LLCAugust 28, 2025 | marketbeat.comComerica Bank Has $27.83 Million Position in Option Care Health, Inc. $OPCHAugust 27, 2025 | marketbeat.comNorthern Trust Corp Has $86.87 Million Stake in Option Care Health, Inc. $OPCHAugust 27, 2025 | marketbeat.comInvesco Ltd. Has $10.02 Million Stake in Option Care Health, Inc. $OPCHAugust 27, 2025 | marketbeat.comAxiom Investors LLC DE Buys 190,417 Shares of Option Care Health, Inc. $OPCHAugust 26, 2025 | marketbeat.comOption Care Health To Participate in Upcoming Investor ConferencesAugust 25, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4By Leo Miller | August 18, 2025Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to BuyBy Thomas Hughes | August 6, 2025Ozempic Boom: Hims & Eli Lilly Lead Healthcare BetsBy Gabriel Osorio-Mazilli | August 21, 2025ARDT, HIMS, OPCH, and GH Company DescriptionsArdent Health NYSE:ARDT$12.78 +0.11 (+0.85%) Closing price 09/3/2025 03:59 PM EasternExtended Trading$12.78 +0.01 (+0.05%) As of 09/3/2025 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Guardant Health NASDAQ:GH$65.06 -1.45 (-2.18%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$65.64 +0.58 (+0.89%) As of 09/3/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$44.50 +2.97 (+7.16%) Closing price 09/3/2025 03:59 PM EasternExtended Trading$44.96 +0.46 (+1.04%) As of 09/3/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$28.93 +0.49 (+1.72%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$29.02 +0.09 (+0.31%) As of 09/3/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Wall Street Punishes Dell's Record Quarter: Why They Are Wrong Taiwan Semiconductor Falls on China News—Buy The Dip? CrowdStrike Tests $412 Support as Options Traders Turn Bullish What to Expect From the Q3 Reporting Season IREN Is Up 186% YTD on AI Pivot—And It’s Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
